| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.731 | 15.602 | 3.279 | 614 | 0 | 0 | 2.385 | 0 | 0 | 203 |
| Total Income - EUR | 36.732 | 21.493 | 3.670 | 2.040 | 438 | 174 | 2.785 | 0 | 17.705 | 1.108 |
| Total Expenses - EUR | 17.806 | 4.977 | 2.634 | 1.748 | 328 | 1.670 | 2.280 | 0 | 17.491 | 817 |
| Gross Profit/Loss - EUR | 18.926 | 16.516 | 1.037 | 292 | 110 | -1.496 | 505 | 0 | 214 | 291 |
| Net Profit/Loss - EUR | 17.831 | 15.872 | 938 | 231 | 97 | -1.501 | 435 | 0 | 180 | 245 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Dava Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.779 | 12.495 | 12.060 | 10.822 | 10.586 | 10.361 | 83.361 | 70.457 | 54.836 | 54.529 |
| Current Assets | 36.460 | 45.425 | 40.897 | 34.984 | 34.296 | 32.507 | 31.784 | 11.166 | 12.838 | 12.864 |
| Inventories | 10.265 | 10.181 | 10.053 | 9.868 | 10.117 | 9.497 | 9.891 | 9.922 | 9.892 | 9.837 |
| Receivables | 22.890 | 26.700 | 23.460 | 21.940 | 21.614 | 19.368 | 21.284 | 46 | 195 | 135 |
| Cash | 3.306 | 8.543 | 7.384 | 3.175 | 2.565 | 3.642 | 609 | 1.197 | 2.751 | 2.893 |
| Shareholders Funds | 30.347 | 45.909 | 46.070 | 45.455 | 44.446 | 42.229 | 41.727 | 41.857 | 41.910 | 41.741 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.893 | 12.011 | 6.887 | 350 | 437 | 639 | 73.418 | 39.766 | 25.764 | 25.652 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4712 - 4712" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Bio Dava Srl